Back to all news

FDA Approves AI Software for Brain Aneurysm Detection on CTA

Tags:CTFDA
FDA Approves AI Software for Brain Aneurysm Detection on CTA

FDA cleared Uptunity, an AI software, to aid radiologists in detecting brain aneurysms on CT angiography.

Key Details

  • 1Uptunity, an AI software for brain aneurysm detection, received FDA clearance.
  • 2The tool is designed to assist with CT angiography interpretation and follow-up.
  • 3It was developed by Bracco in collaboration with Avicenna.AI.
  • 4Around 1 in 50 U.S. adults have unruptured brain aneurysms, which can be asymptomatic and difficult to detect.
  • 5The software integrates with existing radiology reading environments.

Why It Matters

FDA clearance signals clinical readiness of AI tools to support radiologists in identifying challenging neurovascular findings, potentially improving diagnostic accuracy and workflow especially for high-prevalence, subtle conditions.
Radiology Business

Source

Radiology Business

View all from this source

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.